Judge Stacey G. C. Jernigan approved a wind-down bankruptcy plan for CVS Health Corp. subsidiary Omnicare LLC on September 17, 2026. The plan resolves a $949 million Medicare fraud judgment through a $440 million settlement with the Department of Justice and a $250 million asset sale to GenieRx Holdings. The plan, which goes into effect in October 2026, will pay all creditors in full, allowing CVS to offload future liability and focus on its broader financial turnaround.
Omnicare bankruptcy plan approval
- ▪Judge Stacey G. C. Jernigan of the U.S. Bankruptcy Court for the Northern District of Texas approved a wind-down Chapter 11 bankruptcy plan for CVS Health Corp. subsidiary Omnicare LLC on September 17, 2026.
- ▪The approved Omnicare LLC bankruptcy plan provides payment in full to all creditors and is scheduled to go into effect in October 2026.
DOJ fraud settlement terms
- ▪As part of the Department of Justice settlement, Omnicare LLC agreed to release potential legal claims against its parent company, CVS Health Corp.
- ▪Under a July 2026 settlement with the Department of Justice, CVS Health Corp. agreed to make an upfront payment of $130 million and guarantee the remaining $310 million balance if Omnicare LLC fails to pay by mid-March 2028.
GenieRx asset acquisition
- ▪Judge Stacey G. C. Jernigan approved the $250 million sale of Omnicare LLC assets in May 2026 to GenieRx Holdings, a joint partnership between Milrose Capital LLC and Integro Asset Management LLC.
- ▪The sale of Omnicare LLC assets to GenieRx Holdings is expected to close in October 2026, according to Omnicare attorney Martha Wyrick.
Medicare fraud judgment background
- ▪CVS Health Corp. acquired Omnicare LLC in 2015 to provide pharmacy services to long-term care facilities, anticipating increased demand from the aging Baby Boomer generation.
- ▪The fraud claims against Omnicare LLC were first raised by a whistleblowing pharmacist in 2015, leading to a judgment for filing false claims to Medicare, Medicaid, and Tricare.
- ▪Omnicare LLC filed for Chapter 11 bankruptcy in September 2025, citing billions of dollars in debt, shortly after receiving a $949 million judgment for fraudulently dispensing drugs and billing federal healthcare programs.
CVS financial turnaround efforts
- ▪CVS Health Corp. has been focusing on a larger financial turnaround in 2026, with a specific emphasis on improving its insurance profits.
- ▪CVS Health Corp. did not respond to multiple requests for comment regarding the court approval of the Omnicare LLC bankruptcy plan.
Debatable claims
- ▪Companies should be barred from using bankruptcy to reduce federal fraud penalties
- ▪The DOJ should have held CVS fully liable for Omnicare's fraud judgment
Story comments
Loading comments…